RSPO2
Basic information
Region (hg38): 8:107899316-108083642
Links
Phenotypes
GenCC
Source:
- tetraamelia syndrome 2 (Strong), mode of inheritance: AR
- tetraamelia-multiple malformations syndrome (Supportive), mode of inheritance: AR
- tetraamelia syndrome 2 (Strong), mode of inheritance: AR
- tetraamelia syndrome 2 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Tetraamelia syndrome 2 | AR | Cardiovascular | The condition can involve congenital cardiac anomalies, and awareness may allow early management | Cardiovascular; Craniofacial; Genitourinary; Musculoskeletal; Pulmonary | 8030673; 18837045; 29769720 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (62 variants)
- not_specified (27 variants)
- RSPO2-related_disorder (3 variants)
- Tetraamelia-multiple_malformations_syndrome (2 variants)
- Tetraamelia_syndrome_2 (2 variants)
- Humerofemoral_hypoplasia_with_radiotibial_ray_deficiency (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RSPO2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000178565.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 25 | 2 | 27 | |||
| missense | 1 | 47 | 2 | 50 | ||
| nonsense | 2 | 2 | ||||
| start loss | 0 | |||||
| frameshift | 1 | 1 | 2 | |||
| splice donor/acceptor (+/-2bp) | 1 | 1 | ||||
| Total | 3 | 2 | 48 | 27 | 2 |
Highest pathogenic variant AF is 0.000004342987
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| RSPO2 | protein_coding | protein_coding | ENST00000276659 | 5 | 184370 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 125729 | 0 | 19 | 125748 | 0.0000756 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.496 | 121 | 137 | 0.881 | 0.00000709 | 1613 |
| Missense in Polyphen | 46 | 52.355 | 0.87862 | 592 | ||
| Synonymous | -1.26 | 55 | 44.3 | 1.24 | 0.00000223 | 410 |
| Loss of Function | 2.19 | 5 | 13.8 | 0.363 | 8.33e-7 | 162 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.0000927 | 0.0000919 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.0000560 | 0.0000544 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.000107 | 0.000105 |
| Middle Eastern | 0.0000560 | 0.0000544 |
| South Asian | 0.000102 | 0.0000980 |
| Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Activator of the canonical Wnt signaling pathway by acting as a ligand for LGR4-6 receptors. Upon binding to LGR4-6 (LGR4, LGR5 or LGR6), LGR4-6 associate with phosphorylated LRP6 and frizzled receptors that are activated by extracellular Wnt receptors, triggering the canonical Wnt signaling pathway to increase expression of target genes. Also regulates the canonical Wnt/beta-catenin-dependent pathway and non-canonical Wnt signaling by acting as an inhibitor of ZNRF3, an important regulator of the Wnt signaling pathway. Probably also acts as a ligand for frizzled and LRP receptors. {ECO:0000269|PubMed:21727895, ECO:0000269|PubMed:21909076, ECO:0000269|PubMed:22615920}.;
- Pathway
- Signaling by WNT;Signal Transduction;Regulation of FZD by ubiquitination;TCF dependent signaling in response to WNT
(Consensus)
Recessive Scores
- pRec
- 0.111
Intolerance Scores
- loftool
- 0.420
- rvis_EVS
- -0.01
- rvis_percentile_EVS
- 53.51
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.202
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | High | Medium | High |
| Primary Immunodeficiency | High | High | High |
| Cancer | High | High | High |
Zebrafish Information Network
- Gene name
- rspo2
- Affected structure
- pelvic fin lepidotrichium
- Phenotype tag
- abnormal
- Phenotype quality
- hypoplastic
Gene ontology
- Biological process
- osteoblast differentiation;Wnt signaling pathway;positive regulation of Wnt signaling pathway;bone mineralization;embryonic forelimb morphogenesis;embryonic hindlimb morphogenesis;negative regulation of odontogenesis of dentin-containing tooth;limb development;lung growth;epithelial tube branching involved in lung morphogenesis;trachea cartilage morphogenesis;dopaminergic neuron differentiation;positive regulation of canonical Wnt signaling pathway
- Cellular component
- extracellular region;extracellular space;cell surface
- Molecular function
- signaling receptor binding;frizzled binding;protein binding;heparin binding